Aprea Therapeutics APRE
NASDAQ APRE
$0.51 -0.03 (-5.56%)
As of: Oct 23, 2026 · 1:48 PM EDT

Aprea Therapeutics (APRE) Return on Sales [ROS] (2022 - 2026)

Updated

Analysis

Aprea Therapeutics (APRE) Return on Sales [ROS] (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,133.92 Bn 1,102.51 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.72 Bn 554.59 Bn 17.30 Bn 24.35%
3 AbbVie 506.31 Bn 479.42 Bn 12.70 Bn 37.86%
4 Merck 357.83 Bn 312.21 Bn 12.21 Bn -3.52%
5 Novartis Ag 291.64 Bn 255.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.27 Bn 238.96 Bn 12.86 Bn 20.57%
7 Amgen 238.30 Bn 193.70 Bn 7.24 Bn 34.95%
8 Gilead Sciences 195.34 Bn 169.53 Bn 6.22 Bn -133.21%
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 28.37%
10 Aprea Therapeutics 27.36 Mn -88.69 Mn - -1,123.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,123.41%
Mar 31, 2026 -2,545.12%
Dec 31, 2025 -2,227.38%
Sep 30, 2025 -2,069.03%
Jun 30, 2025 -1,902.95%
Mar 31, 2025 -1,995.63%
Dec 31, 2024 -1,174.70%
Sep 30, 2024 -1,174.80%
Jun 30, 2024 -1,006.06%
Mar 31, 2024 -1,111.37%
Dec 31, 2023 -1,184.36%
Sep 30, 2023 -1,096.73%
Jun 30, 2023 -1,086.10%
Mar 31, 2023 -1,802.78%
Dec 31, 2022 -1,090.84%
Sep 30, 2022 -2,779.32%
Jun 30, 2022 -187,585.55%
API Access

Aprea Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=APRE&period=max&api_key=YOUR_API_KEY